01Research Directions

Creatine Hydrochloride research directions

01Research Directions

Why this compound has a literature

Creatine has one of the largest evidence bases in sports nutrition, but that base was built almost entirely on creatine monohydrate. Creatine hydrochloride is a salt developed to address monohydrate's low aqueous solubility, and the research specific to it is small: a handful of physicochemical characterisations and a small number of clinical trials. This section deliberately separates what has been shown for the salt from what has been shown for the monohydrate, because the two are routinely conflated in commercial material.

02Literature

What the literature investigates

The evidence base belongs to monohydrate, and reviewers say so

This point is stated explicitly in the review literature and is the single most important thing a buyer should carry away. Jäger and colleagues (2011) surveyed novel forms of creatine and reported little to no evidence that any newer form was more effective or safer than monohydrate. Kreider and colleagues (2022) revisited the question in a critical review and categorised marketed creatine forms by whether the evidence for bioavailability and safety was strong, partial or absent, concluding that monohydrate remained the only source with substantial supporting evidence and the form explicitly recommended by professional bodies. Note that these reviews carry declared industry affiliations, which readers should weigh. Neither review reported comparative-effectiveness data placing the hydrochloride salt on equal evidential footing with monohydrate.

Physicochemical characterisation: where the salt does differ

The measurable, reproducible difference is solubility. Gufford and colleagues (2010) determined aqueous solubilities and partition coefficients for six N-methyl guanidinium salts of creatine against creatine monohydrate and reported that the hydrochloride was approximately 38 times more soluble than the monohydrate, with the mesylate about 30 times. The same study compared Caco-2 monolayer permeability for creatine pyruvate, citrate and hydrochloride against monohydrate and reported no significant permeability differences except for the citrate, which was reduced. A separate 2026 review reported the thermodynamic solubility of creatine monohydrate in water at 25 °C as not exceeding 13 g/L and surveyed micronisation and granulation as alternative routes to faster dissolution. Solubility is thus a documented property of the salt; it is not, in itself, evidence about anything downstream of dissolution.

Head-to-head clinical data is limited to a small number of trials

Eghbali and colleagues (2024) ran what is currently the most direct comparison: forty participants aged 18-25 completed eight weeks of resistance training while taking creatine hydrochloride at 0.03 g/kg/day, creatine monohydrate with or without a five-day loading phase, or placebo, with strength, limb cross-sectional area, skeletal muscle mass and body-fat percentage as outcomes. Korovljev and colleagues (2026) randomised 36 perimenopausal and menopausal women to low- and medium-dose creatine hydrochloride (750 and 1,500 mg/day) alone or with creatine ethyl ester over eight weeks, with cognitive, clinical and brain creatine measures. Both are small, both are short, and neither has been replicated. That is the whole head-to-head picture at present; any stronger claim about the salt outruns the published record.

Stability of creatine in solution and under stress

Because the hydrochloride is often specified precisely for liquid and ready-to-mix formats, degradation behaviour is directly relevant. Saiki and colleagues (2025) characterised creatine degradation under thermal stress from 60 to 200 °C, UV exposure, pH variation at pH 3, 8 and 13, and in common beverage matrices including coffee, orange juice and an energy drink, using ATR-FTIR and high-resolution mass spectrometry to identify structural modifications relevant to storage, transport and preparation. The Gufford characterisation also noted that creatine, as an amphoteric compound, is least soluble near its isoelectric point, so solution pH governs both dissolution and stability behaviour. Shelf-life work of this kind is thin relative to the clinical literature, and formulators generally still need their own accelerated stability data on the finished matrix.

03Specification

What this means when you specify the material

Specify on a creatine-base basis. Creatine hydrochloride carries roughly 78% creatine against roughly 88% for the monohydrate, so a gram-for-gram substitution into a monohydrate-derived protocol under-delivers creatine by about 11%. The clinical protocols in the wider creatine literature were run on monohydrate at 3-5 g/day maintenance, and the two published hydrochloride trials used 0.03 g/kg/day and 750-1,500 mg/day respectively. Solubility data supports a dissolution claim only; it does not transfer monohydrate's outcome literature to this salt.

04References

Cited literature

Research context only. Each entry describes what a published study examined and reported. These are not claims about this raw material, and not claims about any finished product. Regulatory and labelling judgements belong to the brand placing the product on its market.

A comparative physicochemical study determined the aqueous solubilities and partition coefficients of six N-methyl guanidinium salts of creatine against creatine monohydrate and reported the hydrochloride to be approximately 38 times more soluble than the monohydrate, with no significant difference in Caco-2 monolayer permeability except for the citrate salt, which was reduced. Gufford BT, Sriraghavan K, Miller NJ, Miller DW, Gu X, Vennerstrom JL, Robinson DH. J Diet Suppl. 2010;7(3):240-252. PMID 22432515 DOI 10.3109/19390211.2010.491507
A critical review categorised marketed forms of creatine by whether evidence for bioavailability and safety was strong, partial or absent, and reported that creatine monohydrate remained the only source with substantial supporting evidence and the form explicitly recommended by professional societies; the authors declared industry affiliations. Kreider RB, Jäger R, Purpura M. Nutrients. 2022;14(5):1035. PMID 35268011 DOI 10.3390/nu14051035
A review of novel forms of creatine reported little to no evidence that any newer form was more effective or safer than creatine monohydrate, whether ingested alone or with other nutrients, and noted that the regulatory status of other creatine forms was less clearly defined than that of monohydrate. Jäger R, Purpura M, Shao A, Inoue T, Kreider RB. Amino Acids. 2011;40(5):1369-1383. PMID 21424716 DOI 10.1007/s00726-011-0874-6
In a randomised trial, forty participants aged 18-25 undertook eight weeks of resistance training with creatine hydrochloride (0.03 g/kg/day), creatine monohydrate with or without a five-day loading phase, or placebo, with strength, limb cross-sectional area, skeletal muscle mass and body-fat percentage among the reported outcomes. Eghbali E, Arazi H, Suzuki K. Physiol Res. 2024;73(5):739-753. PMID 39545789 DOI 10.33549/physiolres.935323
In a randomised controlled trial in 36 perimenopausal and menopausal women, low- and medium-dose creatine hydrochloride (750 and 1,500 mg/day) alone or combined with creatine ethyl ester was evaluated over eight weeks against cognitive, clinical and brain creatine outcomes. Korovljev D, Ostojic J, Panic J, et al. J Am Nutr Assoc. 2026;45(3):199-210. PMID 40854087 DOI 10.1080/27697061.2025.2551184
A multi-analytical study characterised creatine degradation under thermal stress (60-200 °C), UV exposure, pH variation (pH 3, 8 and 13) and common beverage matrices including coffee, orange juice and an energy drink, using ATR-FTIR and high-resolution mass spectrometry to identify structural modifications relevant to storage, transport and preparation. Saiki PY, Sales GM, de Oliveira AN, Catharino RR. Food Res Int. 2025;221(Pt 3):117472. PMID 41214971 DOI 10.1016/j.foodres.2025.117472
A review reported that the thermodynamic solubility of creatine monohydrate in water at 25 °C does not exceed 13 g/L, and surveyed micronisation and granulation approaches to improving dissolution rate and apparent solubility. Albagachiev SA, Pinegina ED, Sadkovskii IA, Krasnyuk II, Mandrik MA. Pharmaceuticals (Basel). 2026;19(1):128. PMID 41599726 DOI 10.3390/ph19010128

Need this grade for your line?

RFQ